Kemerovo, Russian Federation
Kemerovo, Russian Federation
Kemerovo, Russian Federation
Kemerovo, Russian Federation
Kemerovo, Russian Federation
Moscow, Russian Federation
The metabolic syndrome, also known as syndrome X or insulin resistance syndrome, is a global human health issue. It is associated with visceral obesity, insulin resistance, high blood pressure, hypoglycemia, hypocholesterolemia, and cardiovascular diseases. This article describes the anti-metabolic syndrome effect of several biologically active mixes that consisted of rutin, quercetin, and trans-cinnamic acid. The experimental mixes differed in composition and ratio, with trans-cinnamic acid being the most abundant component. Mix 1 included rutin, quercetin, and trans-cinnamic acid (1:1:2), Mix 2 consisted of rutin and trans-cinnamic acid (1:3), Mix 3 was a combination of rutin, quercetin, and trans-cinnamic acid (4:1:15), Mix 4 consisted of quercetin and trans-cinnamic acid (3:1). The effective dose was 100.0 mg/kg for all samples. The hypocholesterolemic activity was studied on 48 male black C57Bl/6 mice with hypercholesterolemia induced by lipoprotein lipase inhibitor Poloxamer 407 (400.0 mg/kg). The hypoglycemic activity was determined in vivo on 42 white Wistar rats. Each rat was administered with an individual concentration of the experimental mix (effective doses: 100.0 mg/kg for the mixes, 5.0 mg/kg for glibenclamide, and 2 000.0 mg/kg for glucose). Blood was sampled from the tip of the tail to record the input data on glucose and total cholesterol. The study revealed a reliable decrease (p < 0.01) in the area under curve for glucose concentration and time (Mix 3), which indicated hypoglycemic potential. All groups demonstrated a certain decrease in glucose, but it was statistically significant only in the animals that received Mix 3. All the mixes exhibited a reliable hypocholesterolemic effect. The tests on triglycerides and low-density lipoproteins revealed no statistically significant differences between the experimental groups. However, those treated with Mixes 2 and 3 demonstrated a trend towards lower triglycerides, and those that received Mixes 1 and 4 had a lower level of low-density lipoproteins. Mixes 2 (rutin + trans-cinnamic acid, 1:3), 3 (rutin + quercetin + trans-cinnamic acid, 4:1:15), and 4 (quercetin + trans-cinnamic acid, 3:1) proved to be suitable for anti-metabolic syndrome bioactive additives.
Trans-cinnamic acid, quercetin, rutin, metabolic syndrome, prevention, in vivo, mice
1. Spivak IM, Slizhov PA, Pleskach NM, Nyrov VA, Panferov EV, et al. Geroprotectors against accelerated and natural aging. Health – The Base of Human Potential: Problems and Ways to Solve Them: Proceedings XIII Annual All–Russian Research and practical Conf. with Intern. Participation, 2018;13(1):133–143. (In Russ.)
2. Lemieux I, Després J-P. Metabolic Syndrome: Past, present and future. Nutrients. 2020;12(11):3501. https://doi.org/https://doi.org/10.3390/nu12113501
3. Pristrom MS, Shtonda MV, Semenenkov II. A look at the problem of premature aging: Approaches to prevention. General Medicine: Journal of Scientific and Practical Therapy. 2021;(1):5–24. (In Russ.) https://elibrary.ru/MSIOAR
4. García-García FJ, Monistrol-Mula A, Cardellach F, Garrabou G. Nutrition, bioenergetics, and metabolic syndrome. Nutrients. 2020;12(9):2785. https://doi.org/10.3390/nu12092785
5. Vesnina AD, Milentyeva IS, Le VM, Fedorova AM, Altshuler OG, et al. Quercetin isolated from Hedysarum neglectum Ledeb. as a preventer of metabolic diseases. Foods and Raw Materials. 2025;13(1):192–201. https://doi.org/10.21603/2308- 4057-2025-1-633
6. Vesnina A, Milentyeva I, Minina V, Kozlova O, Asyakina L. Evaluation of the in vivo anti-atherosclerotic activity of quercetin isolated from the hairy roots of Hedysarum neglectum Ledeb. Life. 2023;13(8):1706. https://doi.org/10.3390/ life13081706
7. Kim J-E, Kim J-S, Jo M-J, Cho E, Ahn S-Y, et al. The Roles and associated mechanisms of adipokines in development of metabolic syndrome. Molecules. 2022;27(2):334. https://doi.org/10.3390/molecules27020334
8. Alemany M. The Metabolic syndrome, a human disease. International Journal of Molecular Sciences. 2024;25(4):2251. https://doi.org/10.3390/ijms25042251
9. Vesnina A, Prosekov A, Atuchin V, Minina V, Ponasenko A. Tackling atherosclerosis via selected nutrition. International Journal of Molecular Sciences. 2022;23(15):8233. https://doi.org/10.3390/ijms23158233
10. Hsu C-N, Hou C-Y, Hsu W-H, Tain Y-L. Early-life origins of metabolic syndrome: Mechanisms and preventive aspects. International Journal of Molecular Sciences. 2021;22(21):11872. https://doi.org/10.3390/ijms222111872
11. Aslanova MA, Vasilevskaya ER, Kotenkova EA, Chernukha IM, Fedulova LV, et al. Scientific approaches to the selection of biologically active substances of animal and plant origin for metabolic syndrome correction. Meat Industry. 2020; (12):18–21. (In Russ.) https://doi.org/10.37861/2618-8252-2020-11-18-21
12. Chekushkina DYu, Milentyeva IS, Le VM, Prosekov AYu, Proskuryakova LA. The biopotential of trans-cinnamic acid. Bulletin of the South Ural State University. Series: Food and Biotechnology. 2024;12(2):87–95. (In Russ.) https://doi.org/https://doi.org/10.14529/food240210
13. Pharmacopoeia.rf. Art.1.2.3.0019.15: Spectrophotometry in sugar studies. Ministry of Health of the Russian Federation. Available from: https://pharmacopoeia.ru/ofs-1-2-3-0019-15-opredelenie-saharov-spektrofotometricheskim-metodom/
14. Mah PT, Laaksonen T, Rades T, Aaltonen J, Peltonen L, et al. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide. Molecular Pharmaceutics. 2014;11(1):234–242. https://doi.org/https://doi.org/10.1021/mp4004145
15. Caron A, Lelong C, Bartels T, Dorchies O, Gury T, et al. Clinical and anatomic pathology effects of serial blood sampling in rat toxicology studies, using conventional or microsampling methods. Regulatory Toxicology and Pharmacology. 2015;72(3):429–439. https://doi.org/10.1016/j.yrtph.2015.05.022
16. Lee U, Kwon MH, Kang HE. Pharmacokinetic alterations in poloxamer 407-induced hyperlipidemic rats. Xenobiotica. 2019;49(5):611–625. https://doi.org/10.1080/00498254.2018.1466212
17. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–97. https://doi.org/10.1001/ jama.285.19.2486
18. Johnston TP, Edwards G, Koulen P. Synergism of mechanisms underlying early-stage changes in retina function in male hyperglycemic db/db mice in the absence and presence of chemically-induced dyslipidemia. Scientific Reports. 2023; 13:17347. https://doi.org/10.1038/s41598-023-44446-3
19. Fedorova AM, Dyshlyuk LS, Milentyeva IS, Loseva AI, Neverova OA, et al. Geroprotective activity of transcinnamic acid isolated from the Baikal skullcap (Scutellaria baicalensis). Food Processing: Techniques and Technology. 2022; 52(3):582–591. (In Russ.) https://doi.org/10.21603/2074-9414-2022-3-2388
20. Faskhutdinova ER, Dmitrieva AI, Milentyeva IS. Effect of trans-cinnamic acid on oxidative stress resistance in Caenorhabditis elegans. Innovative development of agro-industrial, chemical, and forestry complexes and sustainable nature management. 2022. pp. 147–150. (In Russ.)
21. Milentyeva IS, Fedorova AM, Larichev TA, Altshuler OG. Biologically active compounds in Scutellaria baicalensis L. callus extract: Phytochemical analysis and isolation. Foods and Raw Materials. 2023;11(1):172–186. https://doi.org/https://doi.org/10.21603/2308-4057-2023-1-564
22. Solanki N, Patel R. Unraveling the mechanisms of trans-cinnamic acid in ameliorating non-alcoholic fatty liver disease. American Journal of Translational Research. 2023;15(9):5747–5756.
23. Bishehsari F, Voigt RM, Keshavarzian A. Circadian rhythms and the gut microbiota: From the metabolic syndrome to cancer. Nature Reviews Endocrinology. 2020;16:731–739. https://doi.org/10.1038/s41574-020-00427-4
24. Shah SAR, Khan MI, Jawaid H, Qureshi U, Ul-Haq Z, et al. Nicotinamide-cinnamic acid cocktail exerts pancreatic β-cells survival coupled with insulin secretion through ERK1/2 signaling pathway in an animal model of apoptosis. DARU Journal of Pharmaceutical Sciences. 2021;29:483–492. https://doi.org/10.1007/s40199-021-00412-w
25. Yazdi M, Nafari A, Azadpour M, Alaee M, Hadipour Moradi F, et al. Protective effects of cinnamic acid against hyperglycemia induced oxidative stress and inflammation in HepG2 cells. Reports of Biochemistry and Molecular Biology. 2023;12(1):1–12. https://doi.org/10.52547/rbmb.12.1.1
26. Dzampaeva ZhV, Datieva FS, Takoeva EA, Nartikoeva MI. Correction of chronic systemic low-intensity inflammation in metabolic syndrome with complex phytoadaptogens. Journal of New Medical Technologies. 2022;(6):101–107. (In Russ.) https://doi.org/10.24412/2075-4094-2022-6-3-7
27. Alshehri FF. Understanding the prevalence, progression, and management of metabolic syndrome in Saudi Arabia. Saudi Medical Journal. 2023;44(10):973–986. https://doi.org/10.15537/smj.2023.44.10.20230450
